In this Mini Mikkipedia Monday, I break down what you actually need to know about Wegovy (semaglutide), now available in New Zealand. There’s a lot of noise around this weight loss medication—from the science to the stigma—and in this episode, I aim to cut through it with facts and context. I cover how GLP-1 agonists work, what makes them effective, and why they’re not just another “quick fix.” From appetite suppression and craving control to weight maintenance and muscle loss concerns, I offer a balanced look at the pros, cons, and common misconceptions. Plus, I share my take on why we need less judgment and more empathy when it comes to using tools like these in our broken food environment.

Highlights:

The difference between Wegovy and Ozempic: use case and dosing
How GLP-1 receptor agonists impact appetite, cravings, and metabolic health
The role of semaglutide in long-term weight loss and potential downsides
Why muscle loss isn’t a direct effect of the drug—and how to prevent it
The wider implications for public health and why lifestyle vs. medication is a false dichotomy

Contact Mikki:
https://mikkiwilliden.com/
https://www.facebook.com/mikkiwillidennutrition
https://www.instagram.com/mikkiwilliden/
https://linktr.ee/mikkiwilliden

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKI at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.com
Curranz supplement: MIKKI saves you 25% at www.curranz.co.nz or www.curranz.co.uk off your first order

Jeff Towson

The AI-powered Podcast Player